alexa Current Developments In Pharmacovigilance From The Regulator?s Perspective: A Risk Management, Master File And Dictionary Evolution (REMS, PSMF And XEVMPD/IDMP)
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials
October 27-29, 2014 Hyderabad International Convention Centre, India

Mohammad Wasif Khan
ScientificTracks Abstracts: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.012
Abstract
The decision of approving a medicinal product is based on its satisfactory balance between benefits and risks within the conditions specified in the product?s labeling. This decision is also based on the limited information available at the time of approval. The huge exposure to the medicinal product in the post-marketing period will generate new information, which can have an impact on the benefits or risks of the medicinal products. This is the reason behind authorities? periodic safety data requirement and legislation developments. The EMA and the NCAs in the EU and the FDA in the US are empowered to impose certain obligations on authorizing medicinal products, to ensure the appropriate changes to medicinal product?s labeling and to conduct post-authorization safety studies, when new safety information makes them necessary. The pharmacovigilance system in both areas demands expedited and obligations recording and reporting of all available data about the serious unexpected adverse events, medication errors and any suspected transmission of an infectious agent through the medicinal products. US legislation has been significantly enhanced by the title IX of the Food and Drug Administration Amendments Act of 2007 and with four different acts over the last two years, the EU has introduced several changes. Implementation of REMS, PSMF, PBRER, xEVMPD and IDMP are the main features of these changes. The current objective of these initiatives is to ensure that the agencies receive up-to-date, complete and high-quality data and maintaining the data so that it is kept up-to-date and of high quality.
Biography
Mohammad Wasif Khan has completed his MPharm from Jamia Hamdard University, New Delhi. He is the Pharmacovigilance Advisor of Yes Regulatory Healthcare Services India Pvt. Ltd; a premier Germany based service provider in Pharmacovigilance and Regulatory Affairs. He has worked for MAHs, Sponsors, serviceproviders and regulatory authority. His involvement with the regulatory authority included to review the reports submitted by MAHs/sponsors in line with the applicable regulatory authority guidelines and providing the findings and comments on the reports to the companies and providing resolution of their queries. He has also supported regulatory authority in drafting one of the modules of Good Pharmacovigilance Practices.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords